Latest news for Grifols (OTC:GIFLF) Stock

As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.

Grifols SA

Grifols: Q4 Was Positive, Still Too Many Question Marks

Harris Associates International Small Cap Strategy Q1 2024 Commentary

Showcasing Seeking Alpha's May 2024 New Analysts

Grifols receives takeover interest from its founding family, Brookfield fund; to go private

Grifols: Stay On The Sidelines

Grifols: Going Private? Brookfield On The Scene

Undercovered Dozen: Spirit Airlines, HubSpot, Cigna, First Quantum Minerals +

Grifols Class B stock falls as Brookfield reportedly seeks lower price

Grifols: Here Is Why It's Still A 'Buy' Even If Price Goes Down

Grifols, S.A. 2024 Q3 - Results - Earnings Call Presentation

APLUF

ARVN

BKNG

DITHF

DSSMY

DXCM

FLMNF

FLMNY

FLNG

FNKO

FQVLF

GIFLF

GIFOF

GIKLY

GOLD

GOOG

GOOGL

GRFS

HOOD

HUBS

INTC

INTR

JAKK

KNCRF

KNCRY

KREF

KRNGF

KRNGY

LAAOF

MHSDF

NESRF

NEXPF

NEXXY

NSTYY

PARA

PARAA

PSNY

PSNYW

RBRK

SAVE

STJPF

TISNF

TRUBF

USFR

VGLT

VRNOF

VTSCF

VTSCY

Press Releases

ROSEN, A LEADING NATIONAL FIRM, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation – GRFS, GIKLY, GIFOF, GIFLF

Small Cap

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF

ROSEN, NATIONAL TRIAL LAWYERS, Encourages Grifols, S.A. Investors to Inquire About Securities Class Action Investigation - GRFS, GIKLY, GIFOF, GIFLF

Grifols

Comments

Grifols

News

Latest news for Grifols (OTC:GIFLF) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga